Pfizer pertains to Swissmedic for authorisation of some other COVID-19 vaccine – Reuters


People pose with syringe with needle before displayed Pfizer emblem within this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration

Register let’s focus on FREE limitless use of Reuters.com

BERLIN, Sept 22 (Reuters) – Pfizer stated on Thursday it’d posted a credit card applicatoin to Swissmedic for authorisation of the further bivalent COVID-19 vaccine.

The ready-to-use dispersion for injection contained both messenger RNA (mRNA) in the original Pfizer/BioNTech COVID-19 vaccine and mRNA coding for that spike protein of Omicron variants BA.4 and BA.5, Pfizer stated.

Register let’s focus on FREE limitless use of Reuters.com

Reporting by Kirsti Knolle Editing by Paul Carrel

Our Standards: The Thomson Reuters Trust Concepts.

Source